Latest News and Press Releases

Wilmington, Delaware, March 20, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Hepatitis C Testing Market by Technique (Immunoassay, PCR, and Other Techniques), Test...

Wilmington, Delaware, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Vaccine Adjuvants Market by Type (Immunostimulants, Vehicles and Mucosal Adjuvants),...

Austin, TX, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Serological Testing Market Size, Trends and Insights By Technology (ELISA, NAT,...

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

New York, USA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Hepatitis E diagnostic tests market was estimated at USD 53.05 million in 2023. The market valuation is expected to be USD...

Barinthus Bio presents updated data from two clinical trials in people with chronic hepatitis B at EASL Congress 2024.

bioLytical launches the INSTI® HCV Antibody Test in Australia with its inclusion on the Australian Register of Therapeutic Goods (ARTG number: 448926)

May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care providers about hepatitis vaccinations.

Pune, India., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Tuberculosis (TB) is the 13th most significant cause of mortality globally and the second leading infectious disease after COVID-19, according to the...

PRINCETON, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...